Rebecca Sizemore, | |
200 Elizabeth St, Charleston, WV 25311-2119 | |
(304) 348-7740 | |
(304) 348-6671 |
Full Name | Rebecca Sizemore |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 200 Elizabeth St, Charleston, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134305097 | NPI | - | NPPES |
7405086000 | Medicaid | WV |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 9782 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rebecca Sizemore, 501 22nd St, Dunbar, WV 25064-1711 Ph: (304) 766-7655 | Rebecca Sizemore, 200 Elizabeth St, Charleston, WV 25311-2119 Ph: (304) 348-7740 |
News Archive
The Campbell Foundation, a Fort Lauderdale-based nonprofit that provides grants to support alternative clinical approaches to the treatment and prevention of HIV/AIDS, has awarded an $85,000 grant to Gilda Tachedjian, PhD., Head of Life Sciences and Principal Investigator at Burnet Institute in Melbourne, Australia.
Humans and mice have previously unknown and potentially critical differences in one of the genes responsible for Duchenne muscular dystrophy (DMD). Researchers writing in the open access journal BMC Biology have found that two major features of a key DMD gene are present in most mammals, including humans, but are specifically absent in mice and rats, calling into question the use of the mouse as the principal model animal for studying DMD.
Researchers at the San Diego Supercomputer Center (SDSC) at the University of California San Diego have been applying their high-performance computing expertise by porting the popular UniFrac microbiome tool to graphic processing units in a bid to increase the acceleration and accuracy of scientific discovery, including urgently needed COVID-19 research.
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a neurodegenerative disease that primarily kills motor neurons, leading to paralysis and death 2 to 5 years from diagnosis. Currently ALS has no cure. Despite promising early-stage research, the majority of drugs in development for ALS have failed. Now researchers have uncovered a possible explanation.
› Verified 6 days ago
Vicki Horn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 | |
Rebecca Kelley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7770 | |
Hannah Chinn, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 300 Baker Ln, Charleston, WV 25302 Phone: 304-346-2323 | |
Ericka Brown, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 | |
Tiffany N Evans, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1026 Gordon Dr, Charleston, WV 25303 Phone: 304-421-0854 | |
Michelle Renee Robinson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 Wertz Ave, Charleston, WV 25311 Phone: 304-610-7171 | |
Ms. Amanda S Casto, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln Drive, Charleston, WV 25309 Phone: 304-768-4400 |